Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

650 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension.
Hatano M, Yamada H, Fukuda K, Yoshioka K, Funauchi M, Kuwana M, Sata M, Taniguchi M, Nakanishi N, Saito T, Saji T, Sasayama S. Hatano M, et al. Among authors: sasayama s. Heart Vessels. 2015 Nov;30(6):798-804. doi: 10.1007/s00380-014-0544-1. Epub 2014 Jul 16. Heart Vessels. 2015. PMID: 25028167 Clinical Trial.
Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension.
Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kimura T, Kondo T, Matsushita M, Minamino T, Nakanishi N, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Sasayama S. Tahara N, et al. Among authors: sasayama s. Circ J. 2016 May 25;80(6):1478-83. doi: 10.1253/circj.CJ-15-1305. Epub 2016 May 13. Circ J. 2016. PMID: 27180890 Free article.
Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension.
Tanabe N, Ikeda S, Tahara N, Fukuda K, Hatano M, Ito H, Nakayama T, Anzai T, Hashimoto A, Inoue T, Kajinami K, Kihara Y, Kinoshita H, Kuwahara K, Murohara T, Okazaki O, Sakai S, Satoh T, Takeda Y, Takeishi Y, Taniguchi M, Watanabe H, Yamamoto T, Yamauchi-Takihara K, Yoshioka K, Sasayama S. Tanabe N, et al. Among authors: sasayama s. Circ J. 2017 Aug 25;81(9):1360-1367. doi: 10.1253/circj.CJ-16-1348. Epub 2017 Apr 18. Circ J. 2017. PMID: 28420826 Free article. Clinical Trial.
Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients.
Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kondo T, Matsushita M, Minamino T, Nakanishi N, Okano Y, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Hatta M, Sasayama S. Tahara N, et al. Among authors: sasayama s. Curr Med Res Opin. 2020 Jun;36(6):921-928. doi: 10.1080/03007995.2020.1756234. Epub 2020 May 12. Curr Med Res Opin. 2020. PMID: 32298185
Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study).
Fujita M, Sasayama S, Terasaki F, Mitani S, Morimoto T, Yamazaki T, Hayashi D, Kohro T, Okada Y, Nagai R; JCAD Study Investigators. Fujita M, et al. Among authors: sasayama s. Heart Vessels. 2010 Nov;25(6):453-9. doi: 10.1007/s00380-010-0012-5. Epub 2010 Oct 5. Heart Vessels. 2010. PMID: 20922538 Free article.
650 results